The largest database of trusted experimental protocols

4 protocols using rpmi 1640 medium

1

Isolation of Peripheral Blood Mononuclear Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Heparin anti-coagulated blood was obtained from the 14 CF patients in accordance with the ethical guidelines. Briefly, peripheral blood mononuclear cells were isolated from dextran sedimentation followed by Ficoll-Hypaque (GE Healthcare, Little Chalfont, UK) density gradient centrifugation. The upper plasma layer was aspired and the middle phase containing mononuclear cells was collected and washed in RPMI 1640 medium (Aurogene, Roma, Italy). Viability of the cells was determined by Trypan Blue dye extrusion and resulted in ≥98% viable MNCs.
+ Open protocol
+ Expand
2

Comprehensive Antioxidant Characterization Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
All the chemicals, including Folin-Ciocalteu’s phenol reagent, polyvinylpyrrolidone (PVP), sodium carbonate, tannic acid (98% purity), aluminum chloride hexahydrate (AlCl3·6H2O; Ph Eur purity), quercetin (98% purity), 1,1-diphenyl-2-picrylhydrazyl radical (DPPH; 95% purity), 2,2-azobis (2-methylpropionamidine) dihydrochloride (AAPH; 97% purity), 2,2-azino-bis (3-thylbenzothiazoline-6-sulfonic acid) diammonium salt (ABTS; 98% purity), trolox (97% purity), ferrozine (97% purity), iron (II) sulfate heptahydrate (FeSO4·7H2O; 99% purity), iron (III) chloride (FeCl3·6H2O; 97% purity), hydroxylamine hydrochloride (98% purity), rutin (99% purity), bovine serum albumin, glucose, fructose, sodium azide, iron (II) chloride (FeCl2·4H2O; 99% purity), tert-butyl hydroperoxide (tBOOH; 80% purity), and methanol were purchased from Merck (Darmstadt, Germany). RPMI 1640 medium and fetal bovine serum were provided by Aurogene (Rome, Italy).
+ Open protocol
+ Expand
3

THP-1 Cell Differentiation and Inflammasome Activation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human myelomonocytic THP-1 cells were cultured in RPMI 1640 medium (Aurogene, Rome, Italy) supplemented with fetal bovine serum (10%; Aurogene), L-glutamine (2 mM; Aurogene), penicillin (100 IU/mL; Aurogene) and streptomycin (100 mg/mL; Aurogene). Cell culture medium was replaced every 2−3 days, and the cultures were maintained at 37 °C and 5% CO2 in a fully humidified incubator. The day before each experiment, cells were plated in 48-well culture plates (90.000 cells/well) and were differentiated by treatment with PMA (50 nM, 24 h; Sigma-Aldrich). PMA-differentiated THP-1 cells were washed twice with phosphate-buffered saline (PBS) and primed with LPS (10 μg/mL, 4 h; Sigma-Aldrich) in serum-free medium. Cells were then incubated with compounds dissolved in medium containing 0.1% DMSO for 1 h and cell death was triggered with ATP (5 mM, 90 min; Sigma-Aldrich). MCC950 (Sigma-Aldrich batch #45216 and batch #85021 and from Crysdot (product n. CD31002496; OS05876-18070932) was used in the experiments.
+ Open protocol
+ Expand
4

Cytotoxicity and Oxidative Stress Evaluation

Check if the same lab product or an alternative is used in the 5 most similar protocols
If not otherwise specified, all the substances, among which were 3-(4,5 dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT; CAS number: 298-93-1; purity ≥ 98%), tert-butyl hydroperoxide (tBOOH; 70% wt in H2O), 2,7-dichlorofluorescein diacetate (DCFH-DA; CAS number: 4091-99-0; purity ≥ 97%), anti-NF-E2 primary antibody (ABE413), montelukast (MNT; CAS number: 151767-02-1; purity ≤ 100%), and the solvent dimethyl sulfoxide (DMSO; CAS number: 67-68-5; for molecular biology), were purchased from Merck (Darmstadt, Germany). All the materials used for cell cultures, including the RPMI 1640 medium, fetal bovine serum, cofactors, and antibiotics, were provided by Aurogene (Rome, Italy).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!